MERU VasImmune, Inc. is a dynamic, privately-held biotech company based in the innovative hub of San Diego, California. Founded in 2016 by the visionary Dr. Zaverio M. Ruggeri, our organization is dedicated to pushing the boundaries of scientific discovery in the realms of platelets, coagulation, and vascular biology. With a focused commitment to addressing some of the most challenging health issues, our research targets critical areas including thrombosis, bleeding disorders, infection and immunity, inflammation, and cancer.

At MERU VasImmune, we believe that deep scientific insights can lead to transformative breakthroughs in medicine. Our team of passionate experts leverages cutting-edge technology and a collaborative spirit to uncover novel mechanisms and develop innovative strategies that pave the way for improved diagnostics and therapies. By embracing both rigorous research and creative problem-solving, we are driving forward the frontiers of biomedical science to make a tangible impact on patient care.

Our mission is not only to explore the complex interplay of the body’s hemostatic and immune systems but also to translate our discoveries into real-world applications. Every project we undertake is imbued with the belief that better understanding these biological processes can lead to revolutionary treatments that alleviate suffering and save lives. Through relentless innovation, strategic partnerships, and a commitment to excellence, MERU VasImmune is shaping the future of healthcare, one discovery at a time.